Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
1.
Am J Infect Control ; 52(1): 66-72, 2024 Jan.
Article in English | MEDLINE | ID: mdl-37543306

ABSTRACT

PURPOSE: We describe the results of an infection control intervention, implemented in 4 tertiary hospitals in Romagna, Italy, aiming at containing the spread of carbapenem-resistant Enterobacterales (CRE). METHODS: The intervention consisted of rectal screening in patients at risk for CRE; pre-emptive contact precaution waiting for screening results; timely notification of CRE identification and concomitant computerized alert; contact precaution for confirmed CRE-positive patients. We performed an interrupted time series analysis to compare the incidence of CRE bacteraemia, of other CRE infections, and CRE-positive rectal swabs in the pre and postintervention period (January 2015-July 2017 and August 2017-June 2020, respectively). RESULTS: 4,332 CRE isolates were collected. Klebsiella pneumoniae was the most represented pathogen (n = 3,716, 85%); KPC production was the most common resistance mechanism (n = 3,896, 90%). The incidence rate of CRE bacteraemia significantly decreased from 0.554 to 0.447 episodes per 10.000 patient days in the early postintervention period (P = .001). The incidence rate of other CRE infections significantly decreased from 2.09 to 1.49 isolations per 10.000 patient days in the early postintervention period (P = .021). The monthly number of rectal swabs doubled in the postintervention period and there was a significant reduction trend of CRE-positive swabs, sustained over time (P < .001). CONCLUSIONS: The infection control intervention was successful in containing the spread of CRE infections and colonisations.


Subject(s)
Anti-Bacterial Agents , Bacteremia , Humans , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Carbapenems/pharmacology , beta-Lactamases , Bacterial Proteins , Trust , Infection Control/methods , Hospitals , Klebsiella pneumoniae , Bacteremia/epidemiology , Bacteremia/prevention & control , Bacteremia/drug therapy
2.
Dig Dis Sci ; 67(4): 1116-1127, 2022 04.
Article in English | MEDLINE | ID: mdl-35318553

ABSTRACT

Biliary lithiasis is common worldwide, affecting almost 20% of the general population, though few experience symptoms. The frequency of choledocholithiasis in patients with symptomatic cholelithiasis is estimated to be 10-33%, depending on patients' age. Unlike gallbladder lithiasis, the medical and surgical treatment of common bile duct stones is uncertain, having changed over the last few years. The prior gold standard treatment for cholelithiasis and choledocholithiasis was open cholecystectomy with bile duct clearance, choledochotomy, and/or surgical sphincterotomy. In the last 10-15 years, new treatment approaches to the complex pathology of choledocholithiasis have emerged with the advent of endoscopic retrograde cholangiopancreatography (ERCP), laparoscopic surgery, and advanced diagnostic procedures. Although ERCP followed by laparoscopic cholecystectomy is the preferred mode of management, a single-step strategy (laparo-endoscopic rendezvous) has gained acceptance due to lesser morbidity and a lower risk of iatrogenic damage. Given the above, a tailored approach relying on careful evaluation of the disease is necessary in order to minimize complication risks and overall costs. Yet, the debate remains open, with no consensus on the superiority of laparo-endoscopic rendezvous to more conventional approaches.


Subject(s)
Cholecystectomy, Laparoscopic , Choledocholithiasis , Gallstones , Cholangiopancreatography, Endoscopic Retrograde , Cholecystectomy, Laparoscopic/adverse effects , Cholecystectomy, Laparoscopic/methods , Choledocholithiasis/diagnostic imaging , Choledocholithiasis/surgery , Gallstones/complications , Humans
3.
Dig Dis Sci ; 65(1): 66-70, 2020 01.
Article in English | MEDLINE | ID: mdl-31732908

ABSTRACT

Pancreatic pseudocysts commonly complicate acute pancreatitis. They can evolve either asymptomatically or with important symptoms. Treatment can be surgical, endoscopic, or percutaneous. The authors present a case report of a 78-year-old man who developed symptoms of an acute abdomen during hospitalization. A CT scan showed two pancreatic pseudocysts (diameters 10 cm and 7.5 cm) that were successfully drained endoscopically. Multiple pancreatic pseudocysts can be treated successfully via an endoscopic approach.


Subject(s)
Drainage/methods , Endoscopy, Digestive System , Pancreatic Pseudocyst/therapy , Aged , Anti-Bacterial Agents/therapeutic use , Drainage/instrumentation , Endoscopy, Digestive System/instrumentation , Enterobacter/isolation & purification , Humans , Male , Pancreatic Pseudocyst/diagnostic imaging , Pancreatic Pseudocyst/microbiology , Pseudomonas aeruginosa/isolation & purification , Stents , Treatment Outcome
4.
Article in English | MEDLINE | ID: mdl-19416695

ABSTRACT

Fish are important sources of high quality protein, essential minerals such as iodine and selenium, vitamins including A, D and E, and omega-3 fatty acids in the human diet. With declining fisheries worldwide, farmed fish constitute an ever-increasing proportion of fish in the food basket. Sustainable development of aquaculture dictates that diets will have to contain increasing levels of plant products that are devoid of cholesterol, but contain phytosterols that are known to have physiological effects in mammals. Liver X receptors (LXR) are transcription factors whose activity is modulated by sterols, with activation inducing cholesterol catabolism and de novo fatty acid biosynthesis in liver. Transcriptomic analysis has shown that substitution of fish meal and oil with plant products induces genes of cholesterol and fatty acid metabolism in salmonids. Here we report the cloning of LXR cDNAs from two species of salmonid fish that are important in aquaculture. The full-length cDNA (mRNA) of LXR obtained from salmon was shown to be 3766 bp, which included a 5'-untranslated region (UTR) of 412 bp and a 3'-UTR of 1960 bp and an open reading frame (ORF) of 1394 bp, which specified a protein of 462 amino acids. The trout LXR full-length cDNA was 2056 bp, including 5'- and 3'-UTRs of 219 and 547 bp, respectively, and an ORF of 1290 bp, which specified a protein of 427 amino acids. The protein sequences included characteristic features of mammalian LXRs, including the DNA binding (DBD), containing P-box, ligand binding (LBD) and activation function-2 (AF-2) domains, D-box, D (hinge) region, and eight cysteines that belong to the two zinc fingers. Phylogenetic analysis clustered the salmonid LXRs together, more closely with zebrafish and more distantly from medaka and stickleback. A pair-wise comparison among vertebrate LXR sequences showed the amino acid sequence predicted by the salmon LXR ORF showed greatest identity to that of trout 97%, and 97%, 87% and 81% identity to LXRs of zebrafish, frog and human (LXRalpha). The trout LXR ORF showed 96%, 92% and 82% identity to LXRs of zebrafish, frog and human (LXRalpha). Surprisingly, the expression of LXR was lowest in liver of all tissues examined and in salmon the greatest expression was observed in pyloric caeca with liver showing intermediate expression. It is likely that tissue expression was affected by the physiological status of the sampled animals. Certainly, nutritional, environmental and/or developmental regulation was evident in salmon, where the expression of LXR in liver was higher in fish in seawater than in freshwater, and higher in fish fed fish oil compared to fish fed vegetable oil in adult salmon.


Subject(s)
Fish Proteins/genetics , Gene Expression Profiling , Oncorhynchus mykiss/genetics , Orphan Nuclear Receptors/genetics , Salmo salar/genetics , Amino Acid Sequence , Animal Nutritional Physiological Phenomena , Animals , Cloning, Molecular , DNA, Complementary/chemistry , DNA, Complementary/genetics , Fish Oils/administration & dosage , Fresh Water , Gene Expression Regulation/drug effects , Gene Expression Regulation, Developmental/drug effects , Liver/growth & development , Liver/metabolism , Liver X Receptors , Molecular Sequence Data , Oncorhynchus mykiss/growth & development , Orphan Nuclear Receptors/classification , Phylogeny , Plant Oils/administration & dosage , Reverse Transcriptase Polymerase Chain Reaction , Salmo salar/growth & development , Seawater , Sequence Analysis, DNA , Sequence Homology, Amino Acid , Species Specificity , Transcription Factors/genetics
5.
Article in English | MEDLINE | ID: mdl-18304880

ABSTRACT

The high affinity copper transporter 1 (Ctr1), metallothionein (MT) and glutathione reductase (GR) are essential for copper uptake, sequestration and defense respectively. Following rearing on a normal commercial diet (12.6+/-0.2 mg kg(-1) Cu), sea bream were fed an experimental control diet lacking mineral mix (7.7+/-0.3 mg kg(-1) Cu), an experimental diet enhanced with Cu (135+/-4 mg kg(-1) Cu) or an experimental diet (7.7+/-0.3 mg kg(-1) Cu) whilst exposed to Cu in water (0.294+/-0.013 mg L(-1)). Fish were sampled at 0, 15 and 30 days after exposures. Fish fed the Cu-enhanced experimental diet showed lower levels of expression of Ctr1 in the intestine and liver compared to fish fed control experimental diets, whilst Ctr1 expression in the gill and kidney was unaffected by excess dietary Cu exposure. Waterborne-Cu exposure increased Ctr1 mRNA levels in the intestine and the kidney compared to experimental controls. Excess dietary Cu exposure had no effect on levels of metallothionein (MT) mRNA, and the only effect of dietary excess Cu on glutathione reductase (GR) mRNA was a decrease in the intestine. Both MT mRNA and GR were increased in the liver and gill after waterborne-Cu exposure, compared to levels in fish fed experimental control low Cu diets. Thus, Ctr1, MT and GR mRNA expression in response to excess Cu is dependent on the route of exposure. Furthermore, the tissue expression profile of sea bream Ctr1 is consistent with the known physiology of copper exposure in fish and indicates a role both in essential copper uptake and in avoidance of excess dietary and waterborne copper influx.


Subject(s)
Cation Transport Proteins/genetics , Copper/toxicity , Gene Expression/drug effects , Glutathione Reductase/genetics , Metallothionein/genetics , Sea Bream , Amino Acid Sequence , Animals , Cation Transport Proteins/metabolism , Copper/administration & dosage , Copper Transporter 1 , Diet , Gills/drug effects , Gills/metabolism , Glutathione Reductase/metabolism , Humans , Intestinal Mucosa/metabolism , Intestines/drug effects , Liver/drug effects , Liver/metabolism , Metallothionein/metabolism , Molecular Sequence Data , Oligonucleotide Array Sequence Analysis , RNA, Messenger/metabolism , Sequence Analysis, Protein
6.
Fertil Steril ; 71(3): 536-43, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10065794

ABSTRACT

OBJECTIVE: To assess uterine artery blood flow and endometrial thickness in postmenopausal patients receiving sequential hormone replacement therapy (HRT) at different phases of the treatment. DESIGN: Prospective controlled study. SETTING: Ultrasound and menopause units of the obstetrics and gynecology department of the University of Tor Vergata, Rome, Italy. PATIENT(S): Forty postmenopausal women were treated with cyclic sequential HRT (transdermal E2, 50 microg/d, days 1-21; and dydrogesterone, 10 mg/d, days 12-24). INTERVENTION(S): All patients underwent transvaginal color Doppler sonography in the estrogen (phase E) and progestogen (phase E/P) phases and after uterine bleeding when no hormone was administered (phase 0). MAIN OUTCOME MEASURE(S): Endometrial thickness; systolic, diastolic, and mean velocities; and pulsatility and resistance indices of the uterine arteries. RESULT(S): No statistically significant difference in endometrial thickness between phase E (6.5+/-1.6 mm) and phase E/P (6.0+/-1.7 mm) was observed. In phase 0, compared with phases E and E/P, a statistically significant decrease in endometrial thickness was found (4.1+/-1.2 mm). Doppler flow impedance parameters of uterine arteries during the different phases of the HRT cycle showed no differences between the phases considered. CONCLUSION(S): The decrease in endometrial thickness in phase 0 suggests a protective effect of our cyclic sequential regimen on the endometrium. Dydrogesterone does not interfere markedly with the vasodilatory effect of estrogen on uterine arteries.


Subject(s)
Dydrogesterone/pharmacology , Estrogens/pharmacology , Hormone Replacement Therapy , Progesterone Congeners/pharmacology , Uterus/drug effects , Uterus/diagnostic imaging , Aged , Dydrogesterone/therapeutic use , Endometrium/diagnostic imaging , Endometrium/drug effects , Endometrium/pathology , Estrogens/therapeutic use , Female , Humans , Middle Aged , Postmenopause , Progesterone Congeners/therapeutic use , Prospective Studies , Regional Blood Flow , Ultrasonography, Doppler, Color , Uterus/blood supply
SELECTION OF CITATIONS
SEARCH DETAIL
...